Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBLGNASDAQ:BJDXNASDAQ:LGMKNASDAQ:NDRA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLGBone Biologics$0.83-0.7%$0.75$0.57▼$4.25$2.75M0.531.41 million shs80,040 shsBJDXBluejay Diagnostics$1.69+1.2%$2.43$1.46▼$316.92$2.53M0.4494,004 shs18,147 shsLGMKLogicMark$0.01+2.6%$0.02$0.01▼$24.00$715K1.7647.14 million shs42.78 million shsNDRAENDRA Life Sciences$3.22+1.6%$4.10$2.90▼$577.50$2.38M0.19141,356 shs12,678 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLGBone Biologics-0.68%-8.47%+26.41%-6.26%-47.53%BJDXBluejay Diagnostics+1.20%-8.15%-0.59%-56.33%-99.20%LGMKLogicMark+2.61%0.00%-8.53%-94.31%-99.94%NDRAENDRA Life Sciences+1.58%+4.21%-25.12%-26.48%-99.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBLGBone Biologics0.5649 of 5 stars0.02.00.00.02.50.01.3BJDXBluejay Diagnostics1.1197 of 5 stars0.05.00.00.03.00.00.6LGMKLogicMark1.3873 of 5 stars0.05.00.00.03.90.00.6NDRAENDRA Life Sciences2.5718 of 5 stars3.54.00.00.02.10.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLGBone Biologics 0.00N/AN/AN/ABJDXBluejay Diagnostics 0.00N/AN/AN/ALGMKLogicMark 0.00N/AN/AN/ANDRAENDRA Life Sciences 3.00Buy$50.001,452.80% UpsideCurrent Analyst Ratings BreakdownLatest LGMK, BJDX, BBLG, and NDRA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025NDRAENDRA Life SciencesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$75.00 ➝ $50.00(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLGBone BiologicsN/AN/AN/AN/A$7.42 per shareN/ABJDXBluejay Diagnostics$250K10.10N/AN/A$934.50 per share0.00LGMKLogicMark$9.88M0.07N/AN/A$148.65 per share0.00NDRAENDRA Life SciencesN/AN/AN/AN/A$1,170.18 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLGBone Biologics-$8.95MN/A0.00N/AN/AN/A-124.71%-111.64%8/8/2025 (Estimated)BJDXBluejay Diagnostics-$9.95M-$379.74N/A∞N/AN/A-155.67%-117.82%N/ALGMKLogicMark-$14.55M-$223.50N/A∞N/A-141.96%-124.91%-92.05%8/12/2025 (Estimated)NDRAENDRA Life Sciences-$10.06M-$172.04N/AN/AN/AN/A-127.39%-103.77%8/13/2025 (Estimated)Latest LGMK, BJDX, BBLG, and NDRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025LGMKLogicMark-$0.03-$0.12-$0.09-$0.12$2.23 million$2.59 million5/13/2025Q1 2025BJDXBluejay DiagnosticsN/A-$3.37N/A-$3.37N/AN/A5/12/2025Q1 2025BBLGBone Biologics-$0.48-$0.32+$0.16-$0.32N/AN/A3/31/2025Q4 2024BJDXBluejay Diagnostics-$36.00-$112.37-$76.37-$112.37N/AN/A3/31/2025Q4 2024NDRAENDRA Life Sciences-$4.10-$9.40-$5.30-$20.78N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBLGBone BiologicsN/AN/AN/AN/AN/ABJDXBluejay DiagnosticsN/AN/AN/AN/AN/ALGMKLogicMarkN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLGBone BiologicsN/A14.8914.89BJDXBluejay DiagnosticsN/A6.266.26LGMKLogicMarkN/A3.733.29NDRAENDRA Life SciencesN/A6.106.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLGBone Biologics34.30%BJDXBluejay Diagnostics18.47%LGMKLogicMark7.88%NDRAENDRA Life Sciences1.19%Insider OwnershipCompanyInsider OwnershipBBLGBone Biologics6.10%BJDXBluejay Diagnostics0.37%LGMKLogicMark1.33%NDRAENDRA Life Sciences0.04%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLGBone Biologics23.27 million2.31 millionNot OptionableBJDXBluejay Diagnostics91.49 million551,000Not OptionableLGMKLogicMark2060.59 million2.65 millionNo DataNDRAENDRA Life Sciences20738,000537,000Not OptionableLGMK, BJDX, BBLG, and NDRA HeadlinesRecent News About These CompaniesENDRA Life Sciences (NASDAQ:NDRA) Shares Up 1.9% - What's Next?May 28 at 1:54 AM | americanbankingnews.comENDRA Life Sciences (NASDAQ:NDRA) versus Heart Tronics (OTCMKTS:HRTT) Critical ComparisonMay 23, 2025 | americanbankingnews.comENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | businesswire.comENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business UpdateMarch 31, 2025 | finance.yahoo.comENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 TherapiesMarch 31, 2025 | businesswire.comENDRA Life Sciences Inc Registered Shs NDRAFebruary 2, 2025 | morningstar.comWhat Makes ENDRA Life Sciences (NDRA) a New Strong Buy StockJanuary 28, 2025 | zacks.comENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price RequirementNovember 22, 2024 | businesswire.comENDRA Life Sciences Reports Q3 2024 Results and ProgressNovember 16, 2024 | markets.businessinsider.comENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business UpdateNovember 15, 2024 | finance.yahoo.comStudy Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024November 12, 2024 | finance.yahoo.comENDRA Life Sciences Inc trading halted, news pendingNovember 7, 2024 | markets.businessinsider.comENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European PatentNovember 6, 2024 | finance.yahoo.comWave Life Sciences: Pioneering RNA-Editing with Promising Obesity and Cardiovascular InnovationsNovember 4, 2024 | markets.businessinsider.comWave Life Sciences: Pioneering RNA Editing Technology with Promising Therapeutic PipelineOctober 31, 2024 | markets.businessinsider.comWhat’s Driving ENDRA Life Sciences Inc (NDRA) Stock’s 36.45% Surge Over the Past Month?October 28, 2024 | bovnews.comEndra activates TAEUS system to initiate clinical study at LMU in GermanyOctober 23, 2024 | markets.businessinsider.comLife sciences investor Dimension seeks to raise $500M second fundOctober 23, 2024 | endpts.comWhy ENDRA Life Sciences (NDRA) Stock Is Up 140%October 23, 2024 | benzinga.comLife Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual functionOctober 22, 2024 | ophthalmologytimes.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLGMK, BJDX, BBLG, and NDRA Company DescriptionsBone Biologics NASDAQ:BBLG$0.83 -0.01 (-0.68%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$0.84 +0.01 (+0.80%) As of 05/28/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.Bluejay Diagnostics NASDAQ:BJDX$1.69 +0.02 (+1.20%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$1.75 +0.06 (+3.49%) As of 05/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.LogicMark NASDAQ:LGMK$0.01 +0.00 (+2.61%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$0.01 0.00 (-3.39%) As of 05/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company's devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one's health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.ENDRA Life Sciences NASDAQ:NDRA$3.22 +0.05 (+1.58%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$3.22 -0.01 (-0.16%) As of 05/28/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
